Lunit to Be Featured in 21 AI Imaging Studies on Breast Cancer and Lung Disease at ECR 2026
- Written by PR Newswire
![]() |
- 13 oral presentations included, reaffirming the clinical value of AI-based medical image analysis
- Highlighting key topics such as early risk stratification based on AI abnormality scores and interval cancer classification
SEOUL, South Korea, March 4, 2026 /PRNewswire/ -- Lunit (KRX:32813), a leading provider of AI for cancer diagnostics and...















